141 related articles for article (PubMed ID: 36543392)
1. Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
Suzuki Y; Huang Y; Ferris J; Kulkarni A; Hershman D; Wright JD
Int J Gynecol Cancer; 2023 Jan; 33(1):26-34. PubMed ID: 36543392
[TBL] [Abstract][Full Text] [Related]
2. Hormone Therapy Use After Premature Surgical Menopause Based on Prescription Records: A Population-Based Study.
Jang JH; Arora N; Kwon JS; Hanley GE
J Obstet Gynaecol Can; 2020 Dec; 42(12):1511-1517. PubMed ID: 32723606
[TBL] [Abstract][Full Text] [Related]
3. Hormone Replacement Therapy Prescription after Premature Surgical Menopause.
Garg N; Behbehani S; Kosiorek H; Wasson M
J Minim Invasive Gynecol; 2020; 27(7):1618-1623. PubMed ID: 32173578
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
van der Hoef C; Bawuah Dsane L; Schuur N; Louwers YV; Mens JW; Hikary-Bhal N; van Doorn HC
Maturitas; 2024 Jul; 185():108004. PubMed ID: 38663162
[TBL] [Abstract][Full Text] [Related]
5. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
6. Iatrogenic Menopause After Treatment for Cervical Cancer.
Moss EL; Taneja S; Munir F; Kent C; Robinson L; Potdar N; Sarhanis P; McDermott H
Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):766-775. PubMed ID: 27683104
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
Rauh LA; Pannone AF; Cantrell LA
Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
[TBL] [Abstract][Full Text] [Related]
8. Reoperation and pain-related outcomes after hysterectomy for endometriosis by oophorectomy status.
Long AJ; Kaur P; Lukey A; Allaire C; Kwon JS; Talhouk A; Yong PJ; Hanley GE
Am J Obstet Gynecol; 2023 Jan; 228(1):57.e1-57.e18. PubMed ID: 36029832
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and cervical cancer: a systematic review of the literature.
Vargiu V; Amar ID; Rosati A; Dinoi G; Turco LC; Capozzi VA; Scambia G; Villa P
Climacteric; 2021 Apr; 24(2):120-127. PubMed ID: 33236658
[TBL] [Abstract][Full Text] [Related]
10. The surgical menopause.
C Pillay O; Manyonda I
Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():111-118. PubMed ID: 35568447
[TBL] [Abstract][Full Text] [Related]
11. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy after risk reducing salpingo-oophorectomy in patients with BRCA1 or BRCA2 mutations; a systematic review of risks and benefits.
Gordhandas S; Norquist BM; Pennington KP; Yung RL; Laya MB; Swisher EM
Gynecol Oncol; 2019 Apr; 153(1):192-200. PubMed ID: 30661763
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
[TBL] [Abstract][Full Text] [Related]
14. Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.
King J; Wynne CH; Assersohn L; Jones A
Eur J Cancer; 2011 Jul; 47(11):1623-32. PubMed ID: 21561765
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer risk and hormone replacement therapy among BRCA carriers after risk-reducing salpingo-oophorectomy.
Michaelson-Cohen R; Gabizon-Peretz S; Armon S; Srebnik-Moshe N; Mor P; Tomer A; Levy-Lahad E; Paluch-Shimon S
Eur J Cancer; 2021 May; 148():95-102. PubMed ID: 33743487
[TBL] [Abstract][Full Text] [Related]
16. Hormonal replacement therapy in surgical menopause with underlying endometriosis.
Rattanachaiyanont M; Tanmahasamut P; Angsuwatthana S; Techatraisak K; Inthawiwat S; Leerasiri P
J Med Assoc Thai; 2003 Aug; 86(8):702-7. PubMed ID: 12948267
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
Kotsopoulos J; Huzarski T; Gronwald J; Moller P; Lynch HT; Neuhausen SL; Senter L; Demsky R; Foulkes WD; Eng C; Karlan B; Tung N; Singer CF; Sun P; Lubinski J; Narod SA
Breast Cancer Res Treat; 2016 Jan; 155(2):365-73. PubMed ID: 26780555
[TBL] [Abstract][Full Text] [Related]
18. Hormone Therapy Use Among Young Patients with Cervical Cancer in Southern Saskatchewan.
Lee JS; Wasim AM; Karreman E; Al-Hayki M
J Obstet Gynaecol Can; 2022 Jul; 44(7):757-761. PubMed ID: 35483581
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
Moorhead T; Hannaford P; Warskyj M
Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
[TBL] [Abstract][Full Text] [Related]
20. Managing menopause in an irradiated pelvis - uncharted territory.
Darnborough S
Post Reprod Health; 2024 Jun; 30(2):127-134. PubMed ID: 38458182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
